HOW CAN YOU
OPTIMIZE
OUTCOMES
FOR PATIENTS
WITH TGCT?

The International Clinical Consensus for TGCT highlights cross-collaboration via a multidisciplinary team as being crucial for the care of patients with tenosynovial giant cell tumor (TGCT, also known as pigmented villonodular synovitis [PVNS]).¹ Coordination of care across multiple specialties is key to optimizing patient outcomes. Each discipline plays a key role in TGCT disease management.²

Patients with TGCT should be managed within expert centers by a dedicated, experienced sarcoma multidisciplinary treatment team:¹

PATHOLOGIST RADIOLOGIST ORTHOPEDIC SURGEON PAIN SPECIALIST SURGICAL, RADIATION & MEDICAL ONCOLOGISTS

Other specialists,
such as neurosurgeons and
physical therapists, should
be involved as required¹

MORE CAN BE DONE TO OPTIMIZE PATIENT CARE IN TGCT